Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1Phase 4 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other hematologic neoplasm 1Gastrointestinal 1Breast 1

Conditions

Early Hormone Receptor-positive Breast Cancer 1

Interventions

Exercise 126Surveys and Questionnaires 59Standard of Care 59Early Intervention, Educational 55Methods 54Educational Status 53Magnetic Resonance Spectroscopy 50Acupuncture Therapy 48Blood Specimen Collection 46Radiotherapy 39Mammography 39Control Groups 35Counseling 32Therapeutics 30Practice Guidelines as Topic 30Cyclophosphamide 29Biopsy 28Sentinel Lymph Node Biopsy 27Psychiatric Rehabilitation 27Neoadjuvant Therapy 24Yoga 23Mastectomy, Segmental 23Resistance Training 22Interviews as Topic 21Surgical Procedures, Operative 19Palliative Care 19High-Energy Shock Waves 19Trastuzumab 18Doxorubicin 18Cognitive Behavioral Therapy 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Antineoplastic Agents × Breast × Clear all
NCT04278469 2020-02-20

Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy

Gencurix, Inc.

Phase NA Recruiting
194 enrolled
Breast

Early Hormone Receptor-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡